SCHEMBL7366574

SCHEMBL7366574

COc1cc(C(=O)Oc2ccccc2C(C)=O)cc([N+](=O)[O-])c1OC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
MAPT P10636 4/20 0.53
ALDH1A1 P00352 7/20 0.49
LMNA P02545 3/20 0.49
HTT P42858 2/20 0.47
KDM4E B2RXH2 1/20 0.47
GAA P10253 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CYP3A4 P08684 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
TUBB4A P04350 2/20 0.45
TUBB P07437 2/20 0.45
TUBA3C P0DPH7 2/20 0.45
TUBA1B P68363 2/20 0.45
TUBA4A P68366 2/20 0.45
TUBB4B P68371 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7370467 0.79 TPMT (0.56) MAPTALDH1A1LMNAHTTKMT2A
SCHEMBL30740961 0.78 TPMT (0.59) MAPTALDH1A1HTTKDM4EKMT2A
SCHEMBL8462586 0.78 TPMT (0.59) MAPTALDH1A1HTTKDM4EKMT2A
SCHEMBL28390304 0.77 MAPT (0.60) SMN1; SMN2MAPTALDH1A1LMNAKDM4E
SCHEMBL312128 0.77 MAPT (0.54) SMN1; SMN2MAPTALDH1A1KDM4EL3MBTL1
SCHEMBL29149092 0.76 SMN1; SMN2 (0.49) TSHRSMN1; SMN2MAPTALDH1A1LMNA
SCHEMBL7368574 0.76 TUBB4A (0.57) TSHRSMN1; SMN2MAPTALDH1A1LMNA
SCHEMBL7374869 0.76 ALDH1A1 (0.63) TSHRMAPTALDH1A1LMNAKDM4E
SCHEMBL29149090 0.75 KMT2A (0.53) TSHRSMN1; SMN2MAPTALDH1A1LMNA
SCHEMBL7368386 0.74 TTR (0.58) MAPTALDH1A1LMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed
EP-0237929-B1 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1993-06-02 EP disclosed
EP-0237929-A1 3,5-Disubstituted pyrocatechol derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-23 EP disclosed